Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb;74(2):177-86.
doi: 10.1002/pros.22739. Epub 2013 Oct 22.

Piperlongumine inhibits NF-κB activity and attenuates aggressive growth characteristics of prostate cancer cells

Affiliations

Piperlongumine inhibits NF-κB activity and attenuates aggressive growth characteristics of prostate cancer cells

Serge Ginzburg et al. Prostate. 2014 Feb.

Abstract

Background: Elevated NF-κB activity has been previously demonstrated in prostate cancer cell lines as hormone-independent or metastatic characteristics develop. We look at the effects of piperlongumine (PL), a biologically active alkaloid/amide present in piper longum plant, on the NF-κB pathway in androgen-independent prostate cancer cells.

Methods: NF-κB activity was evaluated using Luciferase reporter assays and Western blot analysis of p50 and p65 nuclear translocation. IL-6, IL-8, and MMP-9 levels were assessed using ELISA. Cellular adhesion and invasiveness properties of prostate cancer cells treated with PL were also assessed.

Results: NF-κB DNA-binding activity was directly down-regulated with increasing concentrations of PL, along with decreased nuclear translocation of p50 and p65 subunits. Expression of IL-6, IL-8, MMP-9, and ICAM-1 was attenuated, and a decrease of cell-to-matrix adhesion and invasiveness properties of prostate cancer cells were observed.

Conclusions: PL-mediated inhibition of NF-κB activity decreases aggressive growth characteristics of prostate cancer cells in vitro.

Keywords: IL-6; IL-8; MMP-9; NF-κB; ROS; adhesion; apoptosis; cytokines; piperlongumine; prostate cancer.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The effect of Piperlongumine (PL) on proliferation of human prostate cancer cell lines (PC-3 and DU-145). Cells were treated with indicated concentrations of PL for 48 hr. Cellular proliferation was assessed using the Cell Titer Blue assay.
Fig. 2
Fig. 2
Levels of NF-κB activity were determined by Luciferase Reporter Assay as described in Materials and Methods section. PC-3, DU-145, and LNCaP cells were pre-incubated with indicated concentrations of PL for 6 hr prior to TNF-α (40 ng/ml) stimulation. Statistical analysis was performed by one-way ANOVA. Statistically significant (P < 0.05) compared with cells cultured in medium alone (*) or TNF-α-induced cells (**).
Fig. 3
Fig. 3
PL attenuates degradation of IκBα and blocks nuclear translocation of p50 and p65 in prostate cancer cells primarily via Akt-independent pathway. PL blocks NF-κB translocation in PC-3 (A), and DU-145 cells (B). PL effects on NF-κB translocation in dose-dependent fashion in PC-3 (C), and DU-145 (D) prostate cancer cell lines. E: PL (10 μM, overnight) effectively blocks both Akt and NF-κB pathways. Levels of the nuclear and cytoplasmic proteins were determined by Western blot analysis with specific antibodies. Expression of Topo I (nuclear extract) and β-actin (cytoplasmic extract) were used to control equal protein loading. Representative data from one of three experiments.
Fig. 4
Fig. 4
PL dramatically reduces expression of cytokines (A) IL-6, (B) IL-8, and (C) MMP-9 in PC-3 cells after TNF-α-mediated activation of NF-κB pathway. Statistical analysis was performed by one-way ANOVA. Statistically significant (P < 0.05) compared with cells cultured in medium alone (*) or TNF-α-induced cells (**).
Fig. 5
Fig. 5
PL reduces invasiveness of PC-3 cells. A: Migration of PC-3 cells through the filters was quantified as described in the Materials and Methods section. Statistical analysis was performed by one-way ANOVA. Statistically significant (P < 0.05) compared with cells cultured in medium alone (*). Representative data from one of three experiments. B: Representative images of PC-3 cells treated under indicated conditions that invaded through the FluoroBlok membrane.
Fig. 6
Fig. 6
Effect of PL on the adhesion of PC-3 cells. Adhesion of PC-3 cells was determined as described in the Materials and Methods section. A: Adhesion capacity is depicted as tumor cell binding and related to100% binding of non-treated control. Statistical analysis was performed by one-way ANOVA. Statistically significant (P <0.05) compared with cells cultured in medium alone (*). Representative data from one of three experiments. B: Representative images of attached PC-3 cells.
Fig. 7
Fig. 7
PL significantly inhibits TNF-α mediated ICAM-1 expression in PC-3 cell line. Normal mouse IgG-FITC was utilized as a negative control (dotted line). X-axis represents fluorescence intensity; Y-axis represents cell number. Representative data from one of three experiments.

References

    1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. - PubMed
    1. El-Amm J, Aragon-Ching JB. The changing landscape in the treatment of metastatic castration-resistant prostate cancer. Ther Adv Med Oncol. 2013;5(1):25–40. - PMC - PubMed
    1. Klein EA, Thompson IM, Jr, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, Minasian LM, Ford LG, Parnes HL, Gaziano JM, Karp DD, Lieber MM, Walther PJ, Klotz L, Parsons JK, Chin JL, Darke AK, Lippman SM, Goodman GE, Meyskens FL, Jr, Baker LH. Vitamin E and the risk of prostate cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT) JAMA. 2011;306(14):1549–1556. - PMC - PubMed
    1. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, Lieber MM, Cespedes RD, Atkins JN, Lippman SM, Carlin SM, Ryan A, Szczepanek CM, Crowley JJ, Coltman CA., Jr The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215–224. - PubMed
    1. Andriole GL, Bostwick D, Brawley OW, Gomella L, Marberger M, Montorsi F, Pettaway C, Tammela TL, Teloken C, Tindall D, Freedland SJ, Somerville MC, Wilson TH, Fowler I, Castro R, Rittmaster RS, Group RS. The effect of dutasteride on the usefulness of prostate specific antigen for the diagnosis of high grade and clinically relevant prostate cancer in men with a previous negative biopsy: Results from the REDUCE study. J Urol. 2011;185(1):126–131. - PubMed

Publication types

MeSH terms